Fulgent Genetics, Inc.
FLGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$43,820 | -$175,239 | $141,923 | $506,239 |
| Dep. & Amort. | $24,928 | $26,143 | $32,662 | $11,004 |
| Deferred Tax | -$5,150 | $7,608 | $831 | -$7,840 |
| Stock-Based Comp. | $44,481 | $42,922 | $32,640 | $15,882 |
| Change in WC | -$7,239 | $2,841 | $2,005 | -$2,676 |
| Other Non-Cash | $7,860 | $122,728 | $43,459 | $15,968 |
| Operating Cash Flow | $21,060 | $27,003 | $253,520 | $538,577 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$40,315 | -$22,207 | -$18,775 | -$23,812 |
| Net Acquisitions | $0 | -$399 | -$182,679 | -$61,868 |
| Inv. Purchases | -$472,415 | -$491,914 | -$432,982 | -$730,490 |
| Inv. Sales/Matur. | $454,065 | $552,643 | $372,710 | $269,591 |
| Other Inv. Act. | $313 | $775 | $412 | $31 |
| Investing Cash Flow | -$58,352 | $38,898 | -$261,314 | -$546,548 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,774 | -$19,996 | -$1,067 | -$11 |
| Stock Issued | $0 | $0 | $0 | $89,475 |
| Stock Repurch. | -$3,124 | -$27,792 | -$76,105 | -$4,155 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $51 | $3 | $31 | $96 |
| Financing Cash Flow | -$4,847 | -$47,785 | -$77,141 | $85,405 |
| Forex Effect | -$55 | -$149 | -$453 | $34 |
| Net Chg. in Cash | -$42,194 | $17,967 | -$85,388 | $77,468 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $97,473 | $79,506 | $164,894 | $87,426 |
| End Cash | $55,279 | $97,473 | $79,506 | $164,894 |
| Free Cash Flow | -$19,255 | $4,796 | $234,745 | $514,733 |